Edition:
United States

Spectranetics Corp (SPNC.OQ)

SPNC.OQ on NASDAQ Stock Exchange Global Select Market

28.00USD
24 Apr 2017
Change (% chg)

-- (--)
Prev Close
$28.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
70,564
52-wk High
$29.70
52-wk Low
$15.70

SPNC.OQ

Chart for SPNC.OQ

About

The Spectranetics Corporation develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system. The Company's products are used to cross, prepare and treat arterial blockages in the heart and legs and to manage pacemaker and defibrillator cardiac... (more)

Overall

Beta: 1.61
Market Cap(Mil.): $1,217.30
Shares Outstanding(Mil.): 43.48
Dividend: --
Yield (%): --

Financials

  SPNC.OQ Industry Sector
P/E (TTM): -- 50.03 30.10
EPS (TTM): -1.35 -- --
ROI: -15.15 6.65 13.21
ROE: -60.77 10.57 14.37

BRIEF-Spectranetics reports Q4 loss per share $0.29

* Spectranetics reports fourth quarter 2016 revenue of $71.9 million

Feb 23 2017

BRIEF-Franklin Resources reports a 6 percent passive stake in Spectranetics as of Dec 31, 2016

* Franklin Resources reports a 6 percent passive stake in Spectranetics Corp as of December 31, 2016 -SEC filing Source text : [ID:http://bit.ly/2jZpMaJ] Further company coverage:

Feb 07 2017

BRIEF-Spectranetics receives CE mark for Stellarex 0.014 drug-coated balloon

* Spectranetics receives CE mark for stellarex 0.014" drug-coated balloon Source text for Eikon: Further company coverage:

Nov 21 2016

BRIEF-Spectranetics posts positive trial results for stellarex drug-coated balloon illumenate

* Spectranetics Corp announces final 12-month results of stellarex drug-coated balloon (DCB) illumenate pivotal trial

Nov 02 2016

BRIEF-Spectranetics files for FDA approval of Stellarex drug-coated balloon

* Spectranetics corp - preparing for our launch into united states market, which we anticipate in second half of 2017

Nov 02 2016

BRIEF-Spectranetics Q3 loss per share $0.31

* Spectranetics reports third quarter 2016 revenue of $68.3 million

Oct 27 2016

More From Around the Web

Earnings vs. Estimates